Opko Health - Der nächste Blockbuster (Seite 295)
eröffnet am 10.12.13 19:42:20 von
neuester Beitrag 07.05.24 22:55:13 von
neuester Beitrag 07.05.24 22:55:13 von
Beiträge: 3.051
ID: 1.189.336
ID: 1.189.336
Aufrufe heute: 5
Gesamt: 261.286
Gesamt: 261.286
Aktive User: 0
ISIN: US68375N1037 · WKN: A0MUUJ · Symbol: XCY
1,2500
USD
-3,85 %
-0,0500 USD
Letzter Kurs 02:00:00 Nasdaq
Neuigkeiten
07.05.24 · globenewswire  |
03.05.24 · globenewswire |
05.03.24 · globenewswire |
27.02.24 · globenewswire |
Werte aus der Branche Pharmaindustrie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 1,8450 | +146,00 | |
| 0,5700 | +55,23 | |
| 0,7200 | +47,03 | |
| 1,0000 | +33,33 | |
| 119,40 | +29,92 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 7,0000 | -12,50 | |
| 13,800 | -13,86 | |
| 4,1900 | -14,49 | |
| 0,9235 | -16,88 | |
| 5,2500 | -19,23 |
Beitrag zu dieser Diskussion schreiben
FeedbackOPKO Confirms Resumption of Common Stock Trading on Nasdaq --> geht wieder weiter: -8.6% z.Z.
http://investor.opko.com/news-releases/news-release-details/…=>
...OPKO Health, Inc. (NASDAQ: OPK) is pleased to confirm that The Nasdaq Stock Market has lifted the trading suspension of OPKO’s shares.
As noted previously, OPKO and 19 other defendants, including Dr. Phillip Frost, its CEO and Chairman, were named in a Complaint filed on September 7 by the Securities and Exchange Commission (“SEC”). The Company will vigorously defend itself against these charges...
=> Angangsverluste teilweise wieder gutgemacht
Antwort auf Beitrag Nr.: 58.686.039 von tomsylver am 12.09.18 22:13:51besten Dank - was Neues, und funktioniert!
Da wurde ich doch gerade ausgetrickst von WO. Da wurde einfach ein Zitat angelet, daß ich so nicht senden wollte...🙄
Wollte eigentlich nur kurz den Link zur Septemberpräsentation posten. Diese wurde aber wohl schon am 06.09. veröffentlicht, also vor dem schwarzen OPKO-Freitag:
http://investor.opko.com/static-files/591ab987-e267-49e4-ba6…
Ein paar Neuigkeiten/Änderungen sind drin.
Wollte eigentlich nur kurz den Link zur Septemberpräsentation posten. Diese wurde aber wohl schon am 06.09. veröffentlicht, also vor dem schwarzen OPKO-Freitag:
http://investor.opko.com/static-files/591ab987-e267-49e4-ba6…
Ein paar Neuigkeiten/Änderungen sind drin.
Antwort auf Beitrag Nr.: 58.675.590 von faultcode am 11.09.18 23:09:35
Zitat von faultcode: obiger Link passt nicht zum Text -- sind auch keine Zahlen, sondern 8-K (mat.event) - was eh schon bekannt ist:
On September 7, 2018, at 14:34:38 Eastern Daylight Time, Nasdaq halted trading in the Company’s common stock pending receipt from the Company of information requested by the exchange related to the allegations contained in the Lawsuit. Nasdaq has advised the Company that trading will remain halted until the exchange is satisfied with OPKO’s response to Nasdaq’s request for information
=> die letzten Zahlen sind hier, 2018Q2 -- 10-Q -- vom August: http://investor.opko.com/sec-filings/sec-filing/10-q/0000944…
=> gibt nichts Neues, außer massenweise solche Artikel: https://www.zerohedge.com/news/2018-09-10/miami-billionaire-…
Trading Spotlight
Antwort auf Beitrag Nr.: 58.675.206 von vonHS am 11.09.18 22:17:45obiger Link passt nicht zum Text -- sind auch keine Zahlen, sondern 8-K (mat.event) - was eh schon bekannt ist:
On September 7, 2018, at 14:34:38 Eastern Daylight Time, Nasdaq halted trading in the Company’s common stock pending receipt from the Company of information requested by the exchange related to the allegations contained in the Lawsuit. Nasdaq has advised the Company that trading will remain halted until the exchange is satisfied with OPKO’s response to Nasdaq’s request for information
=> die letzten Zahlen sind hier, 2018Q2 -- 10-Q -- vom August: http://investor.opko.com/sec-filings/sec-filing/10-q/0000944…
=> gibt nichts Neues, außer massenweise solche Artikel: https://www.zerohedge.com/news/2018-09-10/miami-billionaire-…
On September 7, 2018, at 14:34:38 Eastern Daylight Time, Nasdaq halted trading in the Company’s common stock pending receipt from the Company of information requested by the exchange related to the allegations contained in the Lawsuit. Nasdaq has advised the Company that trading will remain halted until the exchange is satisfied with OPKO’s response to Nasdaq’s request for information
=> die letzten Zahlen sind hier, 2018Q2 -- 10-Q -- vom August: http://investor.opko.com/sec-filings/sec-filing/10-q/0000944…
=> gibt nichts Neues, außer massenweise solche Artikel: https://www.zerohedge.com/news/2018-09-10/miami-billionaire-…
Neben der Handelsaussetzung hat OPKO heute auch Zahlen geliefert, die man hier ansehen kann:
http://investor.opko.com/sec-filings/sec-filing/8-k/00009448…
http://investor.opko.com/sec-filings/sec-filing/8-k/00009448…
Antwort auf Beitrag Nr.: 58.649.085 von faultcode am 08.09.18 11:02:13
MIAMI--(BUSINESS WIRE)--Sep. 11, 2018-- OPKO Health, Inc. (NASDAQ:OPK) has had trading in its common stock halted by The Nasdaq Stock Market, and the exchange has advised OPKO that the halt will continue until the company responds (to Nasdaq’s satisfaction) to the exchange’s request for information related to the previously reported lawsuit filed by the U.S. Securities and Exchange Commission against a number of individuals and entities, including OPKO and its CEO and Chairman Phillip Frost.
As noted previously, the lawsuit does not contain any allegations about OPKO’s financial practices, financial statements or business practices, and OPKO is confident that once a proper investigation is completed and the facts of the case have been fully disclosed, the matter will be resolved favorably for the company.
OPKO is working expeditiously to respond to Nasdaq’s request for information, but it cannot currently estimate when trading will resume.
OPKO Comments on Continued Nasdaq Halt of Trading of Common Stock
http://investor.opko.com/news-releases/news-release-details/…MIAMI--(BUSINESS WIRE)--Sep. 11, 2018-- OPKO Health, Inc. (NASDAQ:OPK) has had trading in its common stock halted by The Nasdaq Stock Market, and the exchange has advised OPKO that the halt will continue until the company responds (to Nasdaq’s satisfaction) to the exchange’s request for information related to the previously reported lawsuit filed by the U.S. Securities and Exchange Commission against a number of individuals and entities, including OPKO and its CEO and Chairman Phillip Frost.
As noted previously, the lawsuit does not contain any allegations about OPKO’s financial practices, financial statements or business practices, and OPKO is confident that once a proper investigation is completed and the facts of the case have been fully disclosed, the matter will be resolved favorably for the company.
OPKO is working expeditiously to respond to Nasdaq’s request for information, but it cannot currently estimate when trading will resume.
Antwort auf Beitrag Nr.: 58.404.117 von tomsylver am 08.08.18 20:42:49alle Finra regulierten Banken / Broker sind zur Offenlegung von Interessenkonflikten für die gesamte Öffentlichkeit verpflichtet. Ich fände es sehr sehr hilfreich wenn zu den Empfehlungen auch die Interessenkonflikte eingestellt würden. Herzlichen Dank !
sc
sc
Antwort auf Beitrag Nr.: 58.647.861 von faultcode am 08.09.18 00:25:31
http://investor.opko.com/news-releases/news-release-details/…
=>
MIAMI--(BUSINESS WIRE)--Sep. 7, 2018-- OPKO Health, Inc. (NASDAQ: OPK) provided the following comment on the lawsuit filed by the U.S. Securities and Exchange Commission earlier today.
“OPKO learned today that the Securities and Exchange Commission has filed a lawsuit in the Southern District of New York against a number of individuals and entities, including OPKO and its CEO and Chairman Phillip Frost.
The SEC failed to provide notice of its intent to sue prior to filing the complaint, which contains serious factual inaccuracies. Had the SEC followed its own standard procedures, OPKO and Dr. Frost would gladly have provided information that would have answered a number of the SEC’s apparent questions, and filing of this lawsuit against them could have been avoided.
OPKO and Dr. Frost have always prided themselves on adhering to the highest standards of financial disclosure, and they are confident that once a proper investigation is completed and the facts of the case have been fully disclosed, the matter will be resolved favorably for them.”
The Company noted that the complaint does not contain any allegations about OPKO’s financial practices, financial statements or business practices...
OPKO Comments on SEC Complaint
September 7, 2018 8:11 PM EDThttp://investor.opko.com/news-releases/news-release-details/…
=>
MIAMI--(BUSINESS WIRE)--Sep. 7, 2018-- OPKO Health, Inc. (NASDAQ: OPK) provided the following comment on the lawsuit filed by the U.S. Securities and Exchange Commission earlier today.
“OPKO learned today that the Securities and Exchange Commission has filed a lawsuit in the Southern District of New York against a number of individuals and entities, including OPKO and its CEO and Chairman Phillip Frost.
The SEC failed to provide notice of its intent to sue prior to filing the complaint, which contains serious factual inaccuracies. Had the SEC followed its own standard procedures, OPKO and Dr. Frost would gladly have provided information that would have answered a number of the SEC’s apparent questions, and filing of this lawsuit against them could have been avoided.
OPKO and Dr. Frost have always prided themselves on adhering to the highest standards of financial disclosure, and they are confident that once a proper investigation is completed and the facts of the case have been fully disclosed, the matter will be resolved favorably for them.”
The Company noted that the complaint does not contain any allegations about OPKO’s financial practices, financial statements or business practices...
Durchsuchen
